Plante Moran Financial Advisors’s VivoSim Labs VIVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-129
Closed -$2.62K 867
2023
Q2
$2.62K Hold
129
﹤0.01% 675
2023
Q1
$3.4K Hold
129
﹤0.01% 671
2022
Q4
$2.19K Hold
129
﹤0.01% 737
2022
Q3
$3K Hold
129
﹤0.01% 769
2022
Q2
$3K Hold
129
﹤0.01% 791
2022
Q1
$6K Hold
129
﹤0.01% 669
2021
Q4
$6K Hold
129
﹤0.01% 801
2021
Q3
$11K Hold
129
﹤0.01% 682
2021
Q2
$15K Hold
129
﹤0.01% 623
2021
Q1
$15K Hold
129
﹤0.01% 590
2020
Q4
$19K Hold
129
0.01% 543
2020
Q3
$12K Hold
129
﹤0.01% 584
2020
Q2
$17K Hold
129
0.01% 462
2020
Q1
$13K Buy
+129
New +$10.4K 0.01% 471
2015
Q1
Sell
-2
Closed -$3K 813
2014
Q4
$3K Buy
+2
New +$3.07K ﹤0.01% 743

Other funds holding VIVS

Plante Moran Financial Advisors's VIVS Position: Q3 2023 in Review

Plante Moran Financial Advisors sold out of VivoSim Labs (VIVS) in Q3 2023, closing a stake of 129 shares — an estimated $2.62K sold.

Plante Moran Financial Advisors first reported a position in VIVS in Q4 2014 and held it in 15 quarters. The position peaked at $19K in Q4 2020. 31 funds tracked by Wall St. Rank hold VIVS as of Q3 2023.

  • Plante Moran Financial Advisors reported no remaining VivoSim Labs position as of Q3 2023 after selling out during the quarter.
  • Plante Moran Financial Advisors sold 129 VivoSim Labs shares in Q3 2023, an estimated $2.62K.
  • Plante Moran Financial Advisors first reported a position in VivoSim Labs in Q4 2014 and held it in 15 quarters.
  • Plante Moran Financial Advisors's VivoSim Labs position peaked at $19K in Q4 2020.
  • 31 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2023.

Based on Plante Moran Financial Advisors's 13F filing for Q3 2023, filed 7 Nov 2023.